the effect of sertraline in dialysis associated hypotentio

Not Applicable

• Conditions: dialysis associated hypotention.; Kidney dialysis?Hypotension; Y84.1?I95

• Registration Number: IRCT201112033043N3
• Lead Sponsor: Tehran University of Medical Science and Health Services

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

inclusion:patient suffer from dialysis associated hypotention

exclusion:systolic dysfunction,patients who can not tolerate sertraline's adverse effect,refusal to participate in the study,usage of midodrin

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hypotention. Timepoint: 4weeks before intervention,during intervention,4weeks after intervention. Method of measurement: mmhg with use of digital barometer.

Secondary Outcome Measures

Name	Time	Method
Complications of hypotention such as cramp,dizziness,headache,neusea and vomiting,. Timepoint: 4weeks before intervention,during intervention,4weeks after intervention. Method of measurement: observation.